275 related articles for article (PubMed ID: 21282357)
21. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of HLA-ABC expression through promoter hypermethylation and downmodulation of MIC-A/B surface expression in LMP2A-positive epithelial carcinoma cell lines.
Singh S; Banerjee S
Sci Rep; 2020 Mar; 10(1):5415. PubMed ID: 32214110
[TBL] [Abstract][Full Text] [Related]
24. Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells.
Kuhn-Hallek I; Sage DR; Stein L; Groelle H; Fingeroth JD
Blood; 1995 Mar; 85(5):1289-99. PubMed ID: 7858259
[TBL] [Abstract][Full Text] [Related]
25. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers.
Bornkamm GW
Int J Cancer; 2009 Apr; 124(8):1745-55. PubMed ID: 19165855
[TBL] [Abstract][Full Text] [Related]
27. l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma.
Sang W; Tu D; Zhang M; Qin Y; Yin W; Song X; Sun C; Yan D; Wang X; Zeng L; Li Z; Xu K; Xu L
J Biochem Mol Toxicol; 2022 Aug; 36(8):e23117. PubMed ID: 35757978
[TBL] [Abstract][Full Text] [Related]
28. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.
Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X
J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723
[TBL] [Abstract][Full Text] [Related]
29. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
30. Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2.
AlQarni S; Al-Sheikh Y; Campbell D; Drotar M; Hannigan A; Boyle S; Herzyk P; Kossenkov A; Armfield K; Jamieson L; Bailo M; Lieberman PM; Tsimbouri P; Wilson JB
Oncogene; 2018 Jul; 37(29):3998-4012. PubMed ID: 29691476
[TBL] [Abstract][Full Text] [Related]
31. Malaria, Epstein-Barr virus infection and the pathogenesis of Burkitt's lymphoma.
Mawson AR; Majumdar S
Int J Cancer; 2017 Nov; 141(9):1849-1855. PubMed ID: 28707393
[TBL] [Abstract][Full Text] [Related]
32. Biology of the lymphomas: cytogenetics, molecular biology, and virology.
Ambinder RF; Griffin CA
Curr Opin Oncol; 1991 Oct; 3(5):806-12. PubMed ID: 1661167
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma.
Shin DY; Kim A; Kang HJ; Park S; Kim DW; Lee SS
Cancer Lett; 2015 Aug; 364(2):89-97. PubMed ID: 25790907
[TBL] [Abstract][Full Text] [Related]
34. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
Rowe M; Kelly GL; Bell AI; Rickinson AB
Semin Cancer Biol; 2009 Dec; 19(6):377-88. PubMed ID: 19619657
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus sustains Burkitt's lymphomas and Hodgkin's disease.
Hammerschmidt W; Sugden B
Trends Mol Med; 2004 Jul; 10(7):331-6. PubMed ID: 15242681
[TBL] [Abstract][Full Text] [Related]
36. Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells.
Zebboudj A; Maroui MA; Dutrieux J; Touil-Boukoffa C; Bourouba M; Chelbi-Alix MK; Nisole S
Biochimie; 2014 Dec; 107 Pt B():247-56. PubMed ID: 25241256
[TBL] [Abstract][Full Text] [Related]
37. The interaction between Vav1 and EBNA1 promotes survival of Burkitt's lymphoma cells by down-regulating the expression of Bim.
Wang R; Wang J; Zhang N; Wan Y; Liu Y; Zhang L; Pan S; Zhang C; Zhang H; Cao Y
Biochem Biophys Res Commun; 2019 Apr; 511(4):787-793. PubMed ID: 30833082
[TBL] [Abstract][Full Text] [Related]
38. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
Robertson KD; Manns A; Swinnen LJ; Zong JC; Gulley ML; Ambinder RF
Blood; 1996 Oct; 88(8):3129-36. PubMed ID: 8874213
[TBL] [Abstract][Full Text] [Related]
39. Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection.
Zhang B; Zong Y; He J; Zhong B; Lin S
Chin Med J (Engl); 2003 Jun; 116(6):913-7. PubMed ID: 12877806
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus nuclear antigen-1 and Myc cooperate in lymphomagenesis.
Drotar ME; Silva S; Barone E; Campbell D; Tsimbouri P; Jurvansu J; Bhatia P; Klein G; Wilson JB
Int J Cancer; 2003 Sep; 106(3):388-95. PubMed ID: 12845679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
